| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 13 |
| 1 | PACLITAXEL | 11 |
| 2 | PACLITAXEL (AIBUMIN-BOUND) | 11 |
| 3 | ADALIMUMAB | 9 |
| 4 | ADALIMUMAB-AATY | 8 |
| 5 | ADALIMUMAB-ADAZ | 8 |
| 6 | ADALIMUMAB-FKJP | 8 |
| 7 | PEMBROLIZUMAB | 8 |
| 8 | SECUKINUMAB | 8 |
| 9 | USTEKINUMAB | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITROUS OXIDE | 2 | 0.0009 |
| 1 | ERTAPENEM SODIUM | 5 | 0.0007 |
| 2 | BRENTUXIMAB VEDOTIN | 6 | 0.0006 |
| 3 | ENTACAPONE | 2 | 0.0005 |
| 4 | ARSENIC TRIOXIDE | 1 | 0.0004 |
| 5 | CALCIFEDIOL | 1 | 0.0004 |
| 6 | PYRIDOXINE HYDROCHLORIDE | 1 | 0.0004 |
| 7 | ELUXADOLINE | 1 | 0.0003 |
| 8 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE | 1 | 0.0003 |
| 9 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 6 | 0.0006 |
| 1 | Catechol-O-Methyltransferase Inhibitor [EPC] | 2 | 0.0004 |
| 2 | mu-Opioid Receptor Agonist [EPC] | 1 | 0.0003 |
| 3 | Interleukin-17A Antagonist [EPC] | 8 | 0.0002 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 15 | 0.0002 |
| 6 | Glinide [EPC] | 1 | 0.0001 |
| 7 | Cholinesterase Inhibitor [EPC] | 2 | 0.0001 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 5 | 0.0001 |
| 9 | Microtubule Inhibitor [EPC] | 16 | 0.0001 |